Core Viewpoint - North Chip Life (688712) officially listed on the Sci-Tech Innovation Board on February 5, with a significant stock price increase of 183.3% on its first trading day [1] Company Overview - North Chip Life is a national high-tech enterprise focused on the research, development, production, and sales of innovative medical devices for precise diagnosis and treatment of cardiovascular diseases [1] - The company aims to provide transformative precision solutions for cardiovascular disease diagnosis and treatment [1] Market Performance - On the first trading day, North Chip Life opened at 50.31 yuan per share, with an intraday high increase exceeding 200%, ultimately closing at 49.64 yuan per share [1] - The total trading volume for the day reached 1.409 billion yuan, with a turnover rate of 75.88%, resulting in a total market capitalization of 20.7 billion yuan [1] Financial Projections - North Chip Life expects to achieve profitability by 2025, with projected operating revenue between 520 million yuan and 560 million yuan, representing a year-on-year growth of 64.24% to 76.88% [1] - The anticipated net profit attributable to shareholders is estimated to be between 78 million yuan and 88 million yuan, reflecting a year-on-year increase of 278.91% to 301.85% [1]
科创板医疗器械板块纳新，北芯生命上市首日收涨183.3%